A survey of palivizumab for infants with cystic fibrosis in the UK.
作者信息
McCormick J, Southern K W
出版信息
Arch Dis Child. 2007 Jan;92(1):87-8. doi: 10.1136/adc.2006.0105338.
Abstract
摘要
相似文献
1
A survey of palivizumab for infants with cystic fibrosis in the UK.英国对帕利珠单抗用于囊性纤维化婴儿的一项调查。
Arch Dis Child. 2007 Jan;92(1):87-8. doi: 10.1136/adc.2006.0105338.
2
Use of Palivizumab for prevention of hospitalization as a result of respiratory syncytial virus in infants with cystic fibrosis.使用帕利珠单抗预防囊性纤维化婴儿因呼吸道合胞病毒感染而住院。
Pediatr Infect Dis J. 2008 Jun;27(6):559-61. doi: 10.1097/INF.0b013e3181673c15.
3
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.帕利珠单抗用于预防囊性纤维化患儿的呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2010 Feb 17(2):CD007743. doi: 10.1002/14651858.CD007743.pub2.
4
Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?帕利珠单抗预防囊性纤维化婴儿呼吸道合胞病毒感染：是否有必要？
Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1113-1118. doi: 10.1007/s10096-018-3225-7. Epub 2018 Mar 19.
5
[Palivizumab prophylaxis against respiratory syncytial virus. Should its indications be reviewed?].[帕利珠单抗预防呼吸道合胞病毒。其适应证是否应重新评估？]
An Pediatr (Barc). 2004 Jan;60(1):87-8. doi: 10.1016/s1695-4033(04)78222-3.
6
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.帕利珠单抗预防囊性纤维化儿童呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2012 Feb 15(2):CD007743. doi: 10.1002/14651858.CD007743.pub3.
7
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.帕利珠单抗用于预防囊性纤维化患儿的呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2013 Jun 5(6):CD007743. doi: 10.1002/14651858.CD007743.pub4.
8
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.帕利珠单抗用于预防囊性纤维化患儿的呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2014 May 22(5):CD007743. doi: 10.1002/14651858.CD007743.pub5.
9
Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants: a note of caution.帕利珠单抗预防高危婴儿呼吸道合胞病毒感染：一则警示
J Paediatr Child Health. 2003 Nov;39(8):637. doi: 10.1046/j.1440-1754.2003.00253.x.
10
Who shall not receive palivizumab?哪些人不应接受帕利珠单抗治疗？
Pediatrics. 2000 Oct;106(4):866. doi: 10.1542/peds.106.4.866.
引用本文的文献
1
Efficacy and Safety of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Disease: An Updated Systemic Review and Meta-Analysis.帕利珠单抗预防呼吸道合胞病毒（RSV）疾病的疗效与安全性：一项更新的系统评价和荟萃分析
Cureus. 2023 Dec 31;15(12):e51375. doi: 10.7759/cureus.51375. eCollection 2023 Dec.
2
Alternative Viewpoint: Efficacy and Effectiveness of Respiratory Syncytial Virus Immunoprophylaxis in Children with Cystic Fibrosis - An Unsolved Question with More to Be Asked.另一种观点：呼吸道合胞病毒免疫预防对囊性纤维化儿童的疗效和有效性——一个有待进一步探讨的未解决问题。
Pharmacotherapy. 2017 Nov;37(11):e120-e121. doi: 10.1002/phar.2029. Epub 2017 Oct 26.
3
The cost-effectiveness of palivizumab in infants with cystic fibrosis in the Canadian setting: A decision analysis model.加拿大背景下帕利珠单抗用于囊性纤维化婴儿的成本效益：一项决策分析模型
Hum Vaccin Immunother. 2017 Mar 4;13(3):599-606. doi: 10.1080/21645515.2016.1235670. Epub 2016 Oct 21.
4
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.帕利珠单抗用于预防囊性纤维化患儿的呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2016 Jul 20;7(7):CD007743. doi: 10.1002/14651858.CD007743.pub6.
5
Anti-RSV prophylaxis efficacy for infants and young children with cystic fibrosis in Ireland.爱尔兰针对患有囊性纤维化的婴幼儿的呼吸道合胞病毒预防效果
Multidiscip Respir Med. 2015 Oct 15;10:32. doi: 10.1186/s40248-015-0029-9. eCollection 2015.
6
Palivizumab immunoprophylaxis effectiveness in children with cystic fibrosis.帕利珠单抗免疫预防在囊性纤维化患儿中的效果。
Pediatr Pulmonol. 2013 Sep;48(9):874-84. doi: 10.1002/ppul.22711. Epub 2012 Nov 8.
7
Respiratory Syncytial Virus Prophylaxis in Special Populations: Is it Something Worth Considering in Cystic Fibrosis and Immunosuppression?特殊人群中的呼吸道合胞病毒预防：在囊性纤维化和免疫抑制患者中是否值得考虑？
J Pediatr Pharmacol Ther. 2011 Apr;16(2):77-86. doi: 10.5863/1551-6776-16.2.77.
8
Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations.特殊人群中的呼吸道住院和呼吸道合胞病毒预防。
Eur J Pediatr. 2012 May;171(5):833-41. doi: 10.1007/s00431-011-1654-8. Epub 2011 Dec 28.
9
A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice.呼吸道合胞病毒流行病学和预防的十年：将证据转化为日常临床实践。
Can Respir J. 2011 Mar-Apr;18(2):e10-9. doi: 10.1155/2011/493056.
本文引用的文献
1
Immunisation in the current management of cystic fibrosis patients.囊性纤维化患者当前管理中的免疫接种
J Cyst Fibros. 2005 May;4(2):77-87. doi: 10.1016/j.jcf.2004.10.003.
Zotero 插件